Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 37 recruiting now full pipeline #122 of 28,707 conditions

Crohn's Disease: full-pipeline trial registry

37 of 106 indexed Crohn's Disease trials are currently recruiting.

Corpus placement: #122 of 28,707 conditions by registered trial count.

106 US clinical trials · 37 currently recruiting · #122 of 28,707 conditions by registered trial count

Crohn's Disease: 106 US clinical trials tracked, 37 recruiting.

Crohn's Disease is the subject of 106 registered US clinical trials on ClinicalTrials.gov, 37 of them currently open to new participants. 46 are in Phase 3-4 (later-stage) and 36 in Phase 1-2 (earlier-stage). The most active sponsor is Takeda, running 13 of these trials.

Enrollment posture brief

Registry condition crohns-disease

OPEN 37 | RECR 35% | LATE 46 | EARLY 36 | RANK #122 | SPON 13

Nearest open-share peer: Hemophilia A (35% recruiting · 43 trials)

Breast Carcinoma58.9%Non-Hodgkin Lymphoma54.2%Cognitive Impairment43.4%Opioid Use43.4%Crohn's Disease (this)35%
Open-enrollment share among volume-matched conditions near Crohn's Disease

Crohn's Disease lists 37 open slots (35% of 106 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Crohn's Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Crohn's Disease is recruiting below its size-band peers.

    37 of 106 indexed trials (34.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Crohn's Disease trials is spread across many organizations.

    Takeda accounts for 13 of 106 trials (12.3%). 52 distinct sponsors appear on at least one study for this condition label.

  3. Typical Crohn's Disease enrolment sits around 196 participants.

    Median target enrolment is 196 among the 106 trials that report a genuine target (sentinel values excluded). 36 of those (34%) plan for fewer than 100 participants.

  4. Crohn's Disease research is mostly interventional.

    90 interventional and 16 observational studies make up this index (84.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 114Phase 222Phase 341Phase 45

Phase Distribution

PhaseTrial count
Phase 1 14
Phase 2 22
Phase 3 41
Phase 4 5

Named interventions

Most-linked intervention names on Crohn's Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
16 trials
Mirikizumab Drug
5 trials
Vedolizumab Drug
5 trials
Upadacitinib Drug
5 trials
Vedolizumab IV Drug
3 trials
Adalimumab Drug
3 trials
Guselkumab Drug
3 trials
Ustekinumab Drug
3 trials

US sites by state

Facility locations filed on Crohn's Disease trials. A trial with sites in several states counts in each.

California 57 trials
Florida 50 trials
New York 35 trials
Illinois 34 trials
Georgia 33 trials
Colorado 33 trials
Connecticut 32 trials
Arizona 30 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Crohn's Disease page

106 registered trials, 37 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 37 Crohn's Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Takeda sponsors the most Crohn's Disease trials on record, review their full trial history before evaluating a specific study. See Takeda's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Crohn's Disease condition card totals 106 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.